跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Y-40
首页
药物
Y-40
Y-40
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
MODIFIED PEPTIDES AND ASSOCIATED METHODS OF USE
EP 4025585 A4
申请人: ADVANCED TECH FOR NOVEL THERAPEUTICS LLC
优先权: 2019
CN
EP
US
WO
7 件公开
Chemical process
US 7799914 B2
申请人: ASTRAZENECA AB
优先权: 2004
CN
EP
US
6 件公开
Polymeric coupling agents and pharmaceutically-active polymers made therefrom
US 2005255079 A1
申请人: SANTERRE PAUL J
优先权: 2004
CN
US
6 件公开
EP 1744787 A4
申请人: INTERFACE BIOLOGICS INC
优先权: 2004
EP
WO
2 件公开
BIOLOGICALLLY ACTIVE NANOPARTICLES OF A CARBONATE-SUBSTITUTED HYDROXYAPATITE, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS INCORPORATING THE SAME
EP 2029480 B1
申请人: COSWELL SPA
优先权: 2006
CN
EP
US
WO
5 件公开
Increasing serum half-life of human IL-11 variants by N-terminal branched PEGylation
US 10335492 B2
申请人: NANSHA BIOLOGICS HONG KONG LTD
优先权: 2015
CN
US
5 件公开
Materials and methods for preparing dimeric growth factors
US 7241593 B2
申请人: ZYMOGENETICS INC
优先权: 2003
US
5 件公开
Single-stranded oligonucleotide
US 11555188 B2
申请人: NISSAN CHEMICAL CORP
优先权: 2017
CN
EP
US
WO
4 件公开
ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
US 2015315222 A1
申请人: UNIVERSAL DISPLAY CORP
优先权: 2014
EP
US
4 件公开
EP 4019526 A1
申请人: UNIVERSAL DISPLAY CORP
优先权: 2018
CN
EP
2 件公开
Organopolysiloxanes containing phosphonic groups, method for the production and use thereof
US 7064226 B2
申请人: PHOSPHONICS LTD
优先权: 2001
US
4 件公开
Acridone inhibitors of IMPDH enzyme
US 7312209 B2
申请人: BRISTOL MYERS SQUIBB CO
优先权: 2002
US
4 件公开
第 1 / 10 页
上一页
下一页
药物
反馈